We are live on ! Find out more
Stanley Druckenmiller

Stanley Druckenmiller Duquesne Family Office

AUM $3.38B
1-Year Est. Return 61.92%
 

Stanley Druckenmiller is the founder of Duquesne Family Office and one of the most closely watched macro investors of his generation. He first became widely known as lead portfolio manager of the Quantum Fund alongside George Soros, including during the famous 1992 bet against the British pound. After returning outside capital, he has continued to invest with a flexible, top-down approach that blends macroeconomic views with concentrated equity and commodity positions.

This Fund
S&P 500
This Quarter Est. Return
+2.36%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$815M
AUM Growth
-$586M
Cap. Flow
-$570M
Cap. Flow %
-69.95%
Top 10 Hldgs %
56.84%
Holding
69
New
24
Increased
2
Reduced
5
Closed
33

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$25.7M
2
GILD icon
Gilead Sciences
GILD
+$21.3M
3
AMGN icon
Amgen
AMGN
+$20.7M
4
MRK icon
Merck
MRK
+$19.4M
5
COST icon
Costco
COST
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 35.25%
2 Consumer Discretionary 16.43%
3 Communication Services 12.04%
4 Materials 7.93%
5 Consumer Staples 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
51
Humana
HUM
$43.5B
-83,900
Closed -$10.7M
LEN icon
52
Lennar Class A
LEN
$21B
-389,128
Closed -$15.5M
META icon
53
Meta Platforms (Facebook)
META
$1.5T
-948,500
Closed -$63.8M
MPC icon
54
Marathon Petroleum
MPC
$91.3B
-246,800
Closed -$9.63M
NXPI icon
55
NXP Semiconductors
NXPI
$59.9B
-324,400
Closed -$21.5M
OXY icon
56
Occidental Petroleum
OXY
$54.8B
-107,926
Closed -$10.6M
PBR icon
57
Petrobras
PBR
$121B
-1,717,000
Closed -$25.1M
PSX icon
58
Phillips 66
PSX
$82.5B
-303,200
Closed -$24.4M
RRC icon
59
Range Resources
RRC
$9.28B
-363,400
Closed -$31.6M
SPY icon
60
State Street SPDR S&P 500 ETF Trust
SPY
$821B
-51,100
Closed -$10M
TEVA icon
61
Teva Pharmaceuticals
TEVA
$40.1B
-1,241,000
Closed -$65.1M
VLO icon
62
Valero Energy
VLO
$88.9B
-198,500
Closed -$9.95M
XLB icon
63
State Street Materials Select Sector SPDR ETF
XLB
$8.52B
-405,200
Closed -$10.1M
XLI icon
64
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
-183,300
Closed -$9.91M
XLK icon
65
State Street Technology Select Sector SPDR ETF
XLK
$123B
-788,800
Closed -$15.1M
SPWR
66
DELISTED
SunPower Corporation Common Stock
SPWR
-382,972
Closed -$10.3M
PXD
67
DELISTED
Pioneer Natural Resource Co.
PXD
-99,800
Closed -$22.9M
SNDK
68
DELISTED
SANDISK CORP
SNDK
-330,600
Closed -$34.5M
DISH
69
DELISTED
DISH Network Corp.
DISH
-414,500
Closed -$27M

Similar funds

Stanley Druckenmiller's Q3 2014 Portfolio in Review

As of Q3 2014, Stanley Druckenmiller held 69 positions worth $815M, down 42% from $1.4B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Stanley Druckenmiller withdrew a net $570M in Q3 2014, closing 33 positions and reducing 5 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $65.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Stanley Druckenmiller opened a new position in Gilead Sciences worth $23.2M.

  • Stanley Druckenmiller's largest Q3 2014 buy was Gilead Sciences: 217,500 shares worth $23.2M.
  • Stanley Druckenmiller added most to Celgene Corp in Q3 2014, an estimated $25.7M increase.
  • Stanley Druckenmiller's biggest Q3 2014 reduction was Alphabet (Google) Class C, cutting an estimated $129M.
  • Stanley Druckenmiller fully exited Teva Pharmaceuticals in Q3 2014, selling an estimated $65.1M.
  • Stanley Druckenmiller's ten largest holdings make up 57% of its $815M portfolio in Q3 2014.
  • Stanley Druckenmiller opened 24 new positions and closed 33 in Q3 2014.
  • Stanley Druckenmiller's portfolio value fell 42% quarter-over-quarter to $815M.

Based on Duquesne Family Office's 13F filing for Q3 2014, filed 14 Nov 2014.